RedHill Biopharma reported $33.3B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
Cronos Group USD 669.04M 843K Mar/2025
RedHill Biopharma USD 33.3B 20.4B Jun/2025